Research groups
David Priestman
Senior Research Fellow
Recent publications
-
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.
Journal article
PLATT F. and PRIESTMAN D., (2020), Acta Neuropathologica Communications
-
Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms.
Journal article
Viana GM. et al, (2020), J Clin Med, 9
-
Brain pathology in MPS patients with neurological forms
Journal article
PRIESTMAN D. and PLATT F., (2020), Journal of Clinical Medicine
-
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Journal article
Huebecker M. et al, (2020), Mol Neurodegener, 15
-
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes.
Journal article
PRIESTMAN D. et al, (2020), Human Molecular Genetics